Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses

Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitors

(2010) Idit Sagiv-Barfi et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Prophylaxis of acute GVHD: manipulate the graft or the environment?

(2008) A. John Barrett et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Are there effective new strategies for the treatment of acute and chronic GvHD?

(2008) Nelson J. Chao   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors

(2008) Xupeng Ge et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CpG-Induced Myeloid CD11b + Gr-1 + Cells Efficiently Suppress T Cell–Mediated Immunoreactivity and Graft-Versus-Host Disease in a Murine Model of Allogeneic Cell Therapy

(2008) Shoshana Morecki et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Prevention and treatment of acute GvHD

(2008) C Messina et al.   BONE MARROW TRANSPLANTATION

Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation

(2008) Tatyana B. Prigozhina et al.   EXPERIMENTAL HEMATOLOGY

Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell Immunity

(2007) Udo F. Hartwig et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION